Copyright
©The Author(s) 2025.
World J Methodol. Jun 20, 2025; 15(2): 99580
Published online Jun 20, 2025. doi: 10.5662/wjm.v15.i2.99580
Published online Jun 20, 2025. doi: 10.5662/wjm.v15.i2.99580
Treatment groups | Mean duration of seizure (seconds) | SEM |
Vehicle (control group) | 22.00 | 1.09 |
Carbamazepine 4 mg/kg | 14.37 | 0.68 |
Carbamazepine 6 mg/kg | 11.63 | 0.39 |
Carbamazepine 8 mg/kg | 10.33a | 0.58 |
Rosuvastatin 10 mg/kg | 23.80 | 1.14 |
Rosuvastatin 20 mg/kg | 21.13 | 0.74 |
Rosuvastatin 30 mg/kg | 22.53 | 0.61 |
Rosuvastatin 10 mg/kg + carbamazepine 4 mg/kg | 10.20a | 0.60 |
- Citation: Tayal V, Mandal A, Haque M I, Mishra A, Kalra BS, Roy V. Anticonvulsant potential of rosuvastatin in combination with carbamazepine and valproate in animal models of epilepsy. World J Methodol 2025; 15(2): 99580
- URL: https://www.wjgnet.com/2222-0682/full/v15/i2/99580.htm
- DOI: https://dx.doi.org/10.5662/wjm.v15.i2.99580